Artwork

Kandungan disediakan oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

BioHealth Capital Region Maintains #3 Ranking: Insights with GEN's Alex Philippidis

36:11
 
Kongsi
 

Manage episode 431122879 series 1551347
Kandungan disediakan oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News. Alex joins the podcast to discuss the latest Top 10 U.S. Biopharma Clusters list, where the BioHealth Capital Region secured its #3 ranking for the second consecutive year.

The conversation highlights the factors that contributed to the success of the top biopharma clusters, focusing on early investments in biotech, the generation of high-quality science, building networks with partners, and broadening clusters beyond anchor businesses. Alex elaborates on how these regions have sustained their scientific excellence and the long-lasting impact of pioneering efforts.

We explore the criteria used for ranking U.S. biopharma clusters, including NIH funding, venture capital funding, laboratory space, and the number of jobs. Alex provides insights into the methodologies and data sources, such as the NIH RePORT database, PitchBook, and regional life sciences groups, that underpin these rankings.

About Alex Philippidis: Alex Philippidis is the Senior Business Editor at Genetic Engineering & Biotechnology News (GEN). Specializing in biopharma business news and industry issues, Alex joined GEN in 2011 after covering research institutes at GenomeWeb and editing the BioRegion News newsletter. With over 20 years of experience in journalism, Alex has reported on various topics for newspapers and has been featured in major media outlets such as the New York Times and the BBC.

Tune in to BioTalk for an insightful discussion with Alex Philippidis as we explore the latest trends and developments in U.S. biopharma clusters, and the ongoing success of the BioHealth Capital Region.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

  continue reading

180 episod

Artwork
iconKongsi
 
Manage episode 431122879 series 1551347
Kandungan disediakan oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh BioHealth Innovation, Inc. (BHI), BioHealth Innovation, and Inc. (BHI) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News. Alex joins the podcast to discuss the latest Top 10 U.S. Biopharma Clusters list, where the BioHealth Capital Region secured its #3 ranking for the second consecutive year.

The conversation highlights the factors that contributed to the success of the top biopharma clusters, focusing on early investments in biotech, the generation of high-quality science, building networks with partners, and broadening clusters beyond anchor businesses. Alex elaborates on how these regions have sustained their scientific excellence and the long-lasting impact of pioneering efforts.

We explore the criteria used for ranking U.S. biopharma clusters, including NIH funding, venture capital funding, laboratory space, and the number of jobs. Alex provides insights into the methodologies and data sources, such as the NIH RePORT database, PitchBook, and regional life sciences groups, that underpin these rankings.

About Alex Philippidis: Alex Philippidis is the Senior Business Editor at Genetic Engineering & Biotechnology News (GEN). Specializing in biopharma business news and industry issues, Alex joined GEN in 2011 after covering research institutes at GenomeWeb and editing the BioRegion News newsletter. With over 20 years of experience in journalism, Alex has reported on various topics for newspapers and has been featured in major media outlets such as the New York Times and the BBC.

Tune in to BioTalk for an insightful discussion with Alex Philippidis as we explore the latest trends and developments in U.S. biopharma clusters, and the ongoing success of the BioHealth Capital Region.

Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).

  continue reading

180 episod

Wszystkie odcinki

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas
Dengar rancangan ini semasa anda meneroka
Main

OSZAR »